# Contrast-Associated Nephropathy Risk Evaluation in Acute Ischemic Stroke After Endovascular Thrombectomy

> **NCT06596603** · — · COMPLETED · sponsor: **Niguarda Hospital** · enrollment: 8000 (actual)

## Conditions studied

- Contrast-Associated Acute Kidney Injury

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06596603
- **Lead sponsor:** Niguarda Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-07-01
- **Target enrollment:** 8000 (ACTUAL)
- **Last updated:** 2025-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06596603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06596603, "Contrast-Associated Nephropathy Risk Evaluation in Acute Ischemic Stroke After Endovascular Thrombectomy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06596603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*